TrialCPT: pharmacometrics & systems pharmacology2022

Population pharmacokinetics modeling and exposure-response analyses of cemiplimab in patients with recurrent or metastatic cervical cancer.

Jenny-Hoa Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.